News Search Results for "avandia"

All Sources  1 - 10 of about 10
All Sources  1 - 10 of about 10
Diabetes Drugs Go Head-to-Head in Study
Title: Diabetes Drugs Go Head-to-Head in Study Category: Health News Created: 12/3/2009 6:10:00 PM Last Editorial Review: 12/4/2009
MedicineNet.com, Fri Dec 04 13:29:03 PST 2009 Yahoo! News
Metformin vs. Sulfonylureas for Diabetes
Researchers report that diabetes patients who used sulfonylureas had a higher risk of death from all causes and a higher risk of heart failure than diabetes patients who used the most widel...
WebMD, Fri Dec 04 16:08:15 PST 2009 Yahoo! News
Diabetes Drugs Go Head-to-Head in Study
Metformin outperforms widely used sulfonylureas, but each patient will be different, experts say.
HealthCentral, Fri Dec 04 12:08:04 PST 2009 Yahoo! News
Diabetes Drugs Go Head-to-Head in Study
THURSDAY, Dec. 3 (HealthDay News) -- A class of drugs still taken by millions of people with type 2 diabetes is associated with a higher risk of dying and heart failure than the newer treat...
HealthDay via Yahoo! News, Thu Dec 03 16:04:05 PST 2009 Yahoo! News
FDA approves Santarus
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved the company
News-Medical-Net, Fri Dec 04 22:15:20 PST 2009 Yahoo! News
Sulfonylureas Linked To Higher Risk Of Heart Problems
Sulfonylureas, a class of drugs long used in the treatment of type 2 diabetes, have been linked with an increased risk of death and cardiac failure over newer treatments, according to resea...
NewsInferno, Fri Dec 04 09:28:33 PST 2009 Yahoo! News
Research finds change in the outlook of people with type 2 diabetes an...
The outlook for individuals with type 2 diabetes and coronary artery disease is not as grim as originally believed, according to new Saint Louis University research published in Circulation...
News-Medical-Net, Wed Dec 02 20:45:24 PST 2009 Yahoo! News
Amgen to present updated data on Nplate at the 2009 ASH meeting
Amgen Inc. today announced that it will present updated long-term safety and efficacy data for Nplate® (romiplostim) in adult chronic immune (idiopathic) thrombocytopenic purpura (ITP). Add...
News-Medical-Net, Tue Dec 01 01:30:24 PST 2009 Yahoo! News
Diabetes Drugs Go Head-to-Head in Study
Metformin outperforms widely used sulfonylureas, but each patient will be different, experts say
Forbes, Thu Dec 03 16:34:33 PST 2009 Yahoo! News
KTVN Channel 2 - Reno Tahoe News Weather, Video - Diabetes Drugs Go He...
THURSDAY, Dec. 3 (HealthDay News) -- A class of drugs still taken by millions of people with type 2 diabetes is associated with a higher risk of dying and heart failure than the newer treat...
KTVN Reno, Fri Dec 04 06:36:15 PST 2009 Yahoo! News